FEC filings through Sep 30, 2026 · FEC bulk filing data · committee C00383463 · files quarterly
SummaryAt a glance
Why it exists
No statement of purpose found on its site.
Money
$27.9K raised, $57K spent, $17.2K cash on hand (through Sep 30, 2026). Where it comes from
Who funds it
63% from donors giving over $200 · 19% from donors giving $200 or less · largest donor Bob Hoffman, $5K. See who funds it
Where it goes
$57K given to candidates and committees, the largest to CHC Bold PAC ($10K) · 58% of its support to Republicans, 21% to Democrats. See where it goes
Lobbying
Association for Accessible Medicines lobbied on 8 issues. See lobbying
Its wordsWhat does this committee say it is for?
No published list of positions
This committee’s site publishes no list of positions we could read, and we found no statement of why it exists. We do not write one for it.
Who it gives toWhich candidates and committees get its money?
Each part reads different filings, so counts and totals can differ.
Party support distribution$16.5K to 10 candidates
Direct PAC contributions and independent expenditures explicitly reported as support, by the party of the candidate they went to.
For candidates $16,500
Republican 58%
Democratic 21%
Other or unresolved 21%
Support by the party of the candidate
Party of the candidate
Candidates
Direct
Independent
Amount
Share
Republican
6
$9,500
$0
$9,500
58%
Democratic
2
$3,500
$0
$3,500
21%
Other or unresolved
2
$3,500
$0
$3,500
21%
Shown support
10
$16,500
$0
$16,500
100%
Contributions are reported money, not endorsements; a PAC giving to both parties is common.
Who this PAC gave to$57,000 in 25 payments
Every contribution on line 23 of the committee’s own Schedule B, which is the filing its summary totals are built from. That line covers federal candidates, party committees and other political committees alike, so a super PAC funding other super PACs appears here rather than under candidate giving.
By recipient
Line 23 contributions by kind and party of recipient
Recipient
Count
Amount
Democratic candidates
2
$3.5K · 6.1%
Republican candidates
6
$9.5K · 17%
Other or unresolved candidates
2
$3.5K · 6.1%
Other PACs and committees
14
$40.5K · 71%
All recipients
24
$57K
By the candidate’s state
Contributions to candidates by the candidate’s state
State
Candidates
Amount
Texas
2
$5K
Kentucky
1
$2.5K
Maryland
1
$2.5K
Virginia
2
$2K
Michigan
1
$1.5K
Wisconsin
1
$1K
Washington
1
$1K
Florida
1
$1K
Recipients 24
Show candidate activity and the money network
Candidate and election activity as the recipients filed it
August Lee Pfluger II1 receipt, latest Nov 4, 2025August Pfluger for Congress · H0TX11230$2.5K
Jamie Raskin1 receipt, latest May 13, 2026Jamie Raskin for Congress · H6MD08457$2.5K
S. Brett Brett Guthrie1 receipt, latest May 4, 2026Guthrie for Congress · H8KY02031$2.5K
John Moolenaar1 receipt, latest Nov 18, 2025Moolenaar for Congress · H4MI04126$1.5K
Candidate contribution rows come from candidate committee Schedule A filings, the same rows the party chart above counts.
Committee money network
Money moving between this committee and other committees, matched on FEC committee ID rather than the name each filing was typed under. Both sides exclude memo entries. The figures here count each committee once, from the itemized transfers read for this section, so they will not match the payment counts under Who this PAC gave to.
Committees funding this one
Committees that reported giving to this one on their own Schedule A filings, grouped by the giver’s committee ID.
Where the money came from $27,900 reported receipts
Itemized (over $200)Donors who have given more than $200 this cycle, so the FEC itemizes (names) them.$17,64063%
Largest donors
Bob HoffmanOne contribution on Feb 3, 2026 · CHIEF COMMERCIAL OFFICER, US GENERICS · LUPIN PHARMACEUTICALS INC · WASHINTON, DC$5,000
John Murphy41 contributions, latest Sep 18, 2026 · PRESIDENT & CEO · ASSOCIATION FOR ACCESSIBLE MEDICINES · WASHINGTON, DC$4,100
Mark Ratner22 contributions, latest Sep 18, 2026 · SENIOR VP GOVERNMENT AFFAIRS · ASSOCIATION FOR ACCESSIBLE MEDICINES · WASHINGTON, DC$2,200
Shana Christrup35 contributions, latest Sep 18, 2026 · SR DIRECTOR, POLICY · ASSOCIATION FOR ACCESSIBLE MEDICINES · WASHINGTON, DC$1,400
Brett Michelin35 contributions, latest Sep 18, 2026 · SR DIR STATE GA · ASSOCIATION FOR ACCESSIBLE MEDICINES · WASHINGTON, DC$1,400
Ashlie Van Meter35 contributions, latest Sep 18, 2026 · SR DIR STATE GA · ASSOCIATION FOR ACCESSIBLE MEDICINES · WASHINGTON, DC$1,400
Jonathan KimballOne contribution on Jan 21, 2026 · VICE PRESIDENT, U.S. AND GLOBAL PUBLIC · SANDOZ · BETHESDA, MD$1,000
Brian Hart25 contributions, latest Sep 18, 2026 · VP COMMUNICATIONS · ASSOCIATION FOR ACCESSIBLE MEDICINES · WASHINGTON, DC$500
Katherine Raab5 contributions, latest Apr 4, 2025 · VP FEDERAL GOVT AFFAIRS · ASSOCIATION FOR ACCESSIBLE MEDICINES · WASHINGTON, DC$500
Bob Gaines7 contributions, latest Sep 18, 2026 · SENIOR DIRECTOR SCIENCES & REGULATORY · ASSOCIATION FOR ACCESSIBLE MEDICINES · WASHINGTON, DC$140
A donor who gave several times appears once. The 10 largest donors by total given are listed. In all, 207 itemized contributions were filed this cycle, totaling $17.6K. FEC contributor lists are public records and cannot be used for commercial solicitation.
Unitemized ($200 or less)Donors who have given $200 or less this cycle, so the FEC does not itemize (name) them.$5,26019%
PACs and other committeesPolitical action committees and other candidates' committees.$5,00018%
The largest of the committees is listed. Counted from the givers' own filings, which can run above the total this committee reports.
Total reported receipts $27,900
Every dollar the committee reported receiving this cycle, split by the source the FEC filing attributes it to. Open a source marked + to see who gave. FEC filings through Sep 30, 2026.
Who donated: where they live, their employers and jobs
Where the donors live $17,640 placed by state
Loading the map
Tap or hover over a state, or focus the map and use the arrow keys, to read its total. Ctrl or ⌘ and scroll to zoom.
under $666
$666+
$2.7K+
$6K+
$10.6K+
none
Top states
Top donor states
Name
Amount
District of Columbia206 contributions · 94%
$16,640
Maryland1 contribution · 5.7%
$1,000
By the state each contributor wrote on the filing. The FEC aggregates every Schedule A line together, so one committee or organization transfer can account for a whole state. Contributors who have given $200 or less this cycle are not itemized and cannot be placed on a map. The FEC’s grouping also counts joint-fundraising memo lines, so these rows can add up to more than the itemized total.
Donors’ employers as filed
Donors’ employers
Employer as filed
Amount
Association For Accessible Medicines205 contributions · 66% of ranked
$11,640
Lupin Pharmaceuticals INC1 contribution · 28% of ranked
$5,000
Sandoz1 contribution · 5.7% of ranked
$1,000
SpendingWhere does the money go?
How the spending splits $57,000 reported
Contributions to candidates and other committeesMoney given to federal candidates, party committees and other PACs.$57,000100%
Team Jordan1 payment · latest Mar 4, 2025 · CONTRIBUTION$2,000
Darrell Issa for Congress1 payment · latest Apr 8, 2025 · CONTRIBUTION$2,000
Total reported disbursements $57,000
Every dollar this committee reported spending this cycle, split by the lines it reports against. Open a line to see who was actually paid on it. FEC filings through Sep 30, 2026.
What the payments were for $57,000 itemized
Given to othersContributions to other candidates, party committees, and PACs.$57,000100%
Filed as
CONTRIBUTION$57,000
Paid to
CHC Bold PAC$10,000
Congressional Black Caucus PAC$5,000
Aspire PAC$5,000
Together Holding Our Majority$5,000
Josh Hawley Victory Committee$3,000
Moderate Democrats PAC$2,500
Total itemized disbursements $57,000
Every itemized payment the committee reported this cycle, sorted by what it said each one was for. The categories are ours; the wording they are matched against is the committee’s own. Open a category to read the filed descriptions and who was paid. FEC filings through Sep 30, 2026.
All 25 itemized payments filed this cycle. Spending below the itemization threshold is not filed line by line.
$57K spent from Jan 2025 to Sep 2026. Most in one report: $31.5K, Jan 1 – Jun 30, 2025.
$57K
Jan 2025Sep 2026
The running total of what the committee’s FEC reports say it spent, independent expenditures included, with a point at the end of each report. The line is straight between reports because a report gives one total for its whole period.
601 NEW JERSEY AVENUE NW STE 850WASHINGTON, DC, 20001
Audits and penalties
None published by the FEC
LobbyingWhat does its sponsor lobby on?
What Association for Accessible Medicines lobbies on 2026 reports
Besides giving through its PAC, Association for Accessible Medicines pays lobbyists to press Congress and federal agencies. Each quarter it, or a firm it hires, files a public report under the Lobbying Disclosure Act saying which topics it worked on, what it spent, and whom it contacted. This is what those reports say.
Spent on lobbying in 2026
$2.5M
Quarterly reports read
22
Bills it named
36
Topics it lobbied on
Each report files its work under official topics. The bar shows how often each topic came up across the reports; open one to read what was filed under it. Naming a bill says the organization lobbied on it, not which side it took.
Copyright/Patent/Trademarkin 13 report entries · 15 bills named
In its own words
H.R.3160/S.1553: Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act.
H.R.3152/S.1546: Patent Eligibility Restoration Act of 2025.
H.R.3269/S.2276: Eliminating Thickets to Increase Competition (ETHIC) Act.
S.2658: Medication Affordability and Patent Integrity Act.
S.1041: Affordable Prescriptions for Patients Act.
S.1096: Preserve Access to Affordable Generics and Biosimilars Act.
H.R.6485/S.43: Skinny Labels, Big Savings Act.
H.R.4570/S.1097: Interagency Patent Coordination and Improvement Act of 2025.
PTO rulemaking on inter partes review.
H.R.5811: Restoring Americas Leadership in Innovation Act of 2025 (RALIA Act).
Settled expectations discretionary denials.
Issues related to patents and generic drugs Monitor S. 1096 - patent settlements Issues relating to review of pharmaceutical patents in inter partes reviews Issues relating to the Patent Trial and Appeal Board Patent thickets - S. 1041 Skinny labeling issues Monitor issues relating to the Patent Eligibility Restoration Act Monitor issues relating to the PREVAIL Act
Monitor S. 1096 - patent settlements Issues relating to review of pharmaceutical patents in inter partes reviews Issues relating to the Patent Trial and Appeal Board Patent thickets - S. 1041 Monitor S. 1040 - product hopping Skinny labeling issues Monitor issues relating to the Patent Eligibility Restoration Act Monitor issues relating to the PREVAIL Act
Patent Issues impacting the generics and biosimilars industry including changes at the PTAB and skinny labeling.
General issues related to patents and access to generics/biosimilars.
H.R.1843: To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
S.1302: Increasing Transparency in Generic Drug Applications Act.
Generic Drug Reporting Requirement Language in Public Law No. 119-60: National Defense Authorization Act for Fiscal Year 2026.
Public Law No. 119-60: National Defense Authorization Act for Fiscal Year 2026.
H.R.1396/S.1891: Producing Incentives for Long-term Production of Lifesaving Supply of Medicine (PILLS) Act.
Drug Shortages.
H.R.5526/S.1954: Biosimilar Red Tape Elimination Act (BRTEA).
American Relief Act, 2025 (PL.
No: 118-158) as it relates to Patent Thickets and Q1/Q2.
H.R.3955/S.2062: RAPID Reserve Act.
H.R.4132/S.2027: Prescription Information Modernization Act of 2025.
S.1414/H.R.__: Expedited Access to Biosimilars Act.
S.3469: BIOSECURE Act of 2025.
Quotas on Controlled Substances.
Hassan Purple Book Proposal.
S.3788: Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings (CLEAR LABELS) Act.
PBM Bid Transparency.
H.R.7148 - Consolidated Appropriations Act, 2026 as it relates to PBM reforms and Q1/Q2.
To amend the Federal Food, Drug, and Cosmetic Act to allow for the approval of an abbreviated new drug application submitted by a subsequent applicant in the case of a failure by a first applicant to commence commercial marketing within a certain period, and for other purposes (H.R.1051).
Trade (domestic/foreign)in 12 report entries · 2 bills named
In its own words
General Trade Issues.
Drug Supply Chain.
Rules of Origin.
Country of Origin Labeling.
Tariffs on Generic Medicines.
Quotas on Generic Medicines.
Increasing Domestic Production of Generics and Biosimilars.
India Trade Negotiations.
United States-Mexico-Canada Agreement.
S.3788: Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings (CLEAR LABELS) Act.
H.R.8269/S.3788: Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings (CLEAR LABELS) Act.
General issues related to generic and biosimilar drug development.
Issues related to manufacturing and pharmaceutical trade.
General trade issues impacting the generic drug industry.
Issues related to manufacturing and pharmaceutical trade.
Offices it contacted
HOUSE OF REPRESENTATIVES
SENATE
White House Office
Medicare/Medicaidin 3 report entries
In its own words
Medicare Part D Reform.
Medicaid Rebate Penalty.
Medicare/Medicaid Inflation Penalties.
Medicare Conditions of Participation.
CMS RFC on Domestic Manufacturing.
CMS Final Rule on Bona Fide Service Fees.
HCPCS Codes.
Tiering.
PBM Bid Transparency.
Medicare Part D Reform. Medicaid Rebate Penalty. Medicare/Medicaid Inflation Penalties. CMS RFC on Domestic Manufacturing. CMS Final Rule on Bona Fide Service Fees. HCPCS Codes. Tiering. PBM Bid Transparency.
Medicare Part D Reform. Medicaid Rebate Penalty. Medicare/Medicaid Inflation Penalties. Medicare Conditions of Participation. CMS RFC on Domestic Manufacturing. PBM Bid Transparency.
Offices it contacted
Centers For Medicare and Medicaid Services (CMS)
HOUSE OF REPRESENTATIVES
SENATE
Natl Economic Council (NEC)
White House Office
Budget/Appropriationsin 1 report entry
In its own words
FDA Funding.
Offices it contacted
HOUSE OF REPRESENTATIVES
SENATE
Who did the lobbying
The organization’s own reports give its total lobbying costs, including any firms it hired; each firm reports what this client paid it.
Association for Accessible MedicinesIts own staff · 3 reports$2.5M
Reported twice a year by the lobbying filer. $72.6K is political giving that also appears in FEC filings.
Rep. Steve Scalise$15K
Rep. Jim Jordan$10K
Rep. Brett Guthrie$5K
Rep. Tom Emmer$5K
Republican Study Committee$5K
Rep. Ben Cline$3.5K
Rep. Darrell Issa$3.5K
Rep. Scott Fitzgerald$3.5K
Rep. August Pfluger$3.3K
Sen. Ben Ray Lujan$2.5K
Matched by name: these reports are filed for “ASSOCIATION FOR ACCESSIBLE MEDICINES”, found by searching “ASSOCIATION FOR ACCESSIBLE MEDICINES”. Lobbying and FEC records share no ID, so an organization that lobbies under another name is missed. Source: LDA.gov, accessed Oct 27, 2026. Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.
ASSOCIATION FOR ACCESSIBLE MEDICINES POLITICAL ACTION COMMITTEE
Filings covered
Through Sep 30, 2026
Data source
FEC bulk filing data
Association for Accessible Medicines PAC is registered with the Federal Election Commission as a PAC (qualified). It is a lobbyist/registrant PAC. Its FEC record names Association for Accessible Medicines as an affiliate. Official FEC summary: Federal Election Commission committee record.
Pages quoted 0 pages
No pages quoted
Nothing from this committee’s or its sponsor’s site is quoted yet.
Linked public records
No approved organization identity yet
The official FEC committee record remains available under Filings.
APAugust PflugerRepublican · U.S. House · TX-11 · via August Pfluger For Congress1 payment, latest Nov 4, 2025 · CONTRIBUTION · FEC filing, Nov 4, 2025$2.5K
BGBrett GuthrieRepublican · U.S. House · KY-02 · via Guthrie For Congress1 payment, latest May 4, 2026 · CONTRIBUTION · FEC filing, May 4, 2026$2.5K
JRJamie RaskinDemocratic · U.S. House · MD-08 · via Jamie Raskin For Congress1 payment, latest May 13, 2026 · CONTRIBUTION · FEC filing, May 13, 2026$2.5K
Bars drawn to $10K, the largest gift total here. 2025–2026 filings.
$57K across 24 recipient committees, or 100% of everything this committee reports spending. The largest 12 are shown.
Built from FEC Schedule A and Schedule B filings for the selected cycle. A committee only appears here if the money was itemized under its FEC committee ID.
Itemized receipts grouped by the words contributors filed. The FEC aggregates every Schedule A line here, so committee and organization money sits alongside individuals; this is not an industry classification. The FEC’s grouping also counts joint-fundraising memo lines, so these rows can add up to more than the itemized total. Gifts of $200 or less ($5,260) are not itemized, so no employer or occupation is filed for them.
Donors’ occupations as filed
Donors’ occupations
Occupation as filed
Amount
Chief Commercial Officer US Generics1 contribution · 28% of ranked
$5,000
President & CEO41 contributions · 23% of ranked
$4,100
SR DIR State GA70 contributions · 16% of ranked
$2,800
Senior VP Government Affairs22 contributions · 12% of ranked
$2,200
SR Director Policy35 contributions · 7.9% of ranked
$1,400
Vice President U S And Global Public1 contribution · 5.7% of ranked
$1,000
VP Communications25 contributions · 2.8% of ranked
$500
VP Federal Govt Affairs5 contributions · 2.8% of ranked
$500
Itemized receipts grouped by the words contributors filed. The FEC aggregates every Schedule A line here, so committee and organization money sits alongside individuals; this is not an industry classification. The FEC’s grouping also counts joint-fundraising memo lines, so these rows can add up to more than the itemized total. Gifts of $200 or less ($5,260) are not itemized, so no employer or occupation is filed for them.
The people, firms and committees paid the most, across every kind of payment. Each share is of everything the committee reported spending this cycle, not only the itemized payments above. A payee that is itself a committee links to its own profile.
H.R.8269/S.3788: Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings (CLEAR LABELS) Act.
American Made Medicines Act.
H.R.7148: Consolidated Appropriations Act, 2026 as it relates to PBM reforms and Q1/Q2.